13
美國 Quidel 公司（Quidel Corporation）成立于 1979 年，總部位于美國，連同其附屬公司，從事傳染病點保健和生殖與婦女健康的診斷解決方案的開發(fā)，制造及銷售。公司現(xiàn)擁有員工共 322 人。是一家在美國納斯達克上市的綜合性臨床診斷產(chǎn)品生產(chǎn)商和健康服務(wù)研發(fā)型企業(yè),股PIAO代碼（Nasdaq: QDEL），其部分快速診斷產(chǎn)品占據(jù)美國主流市場。主要產(chǎn)品包括傳染性疾病的診斷、生殖健康及孕期診斷、癌癥輔助診斷、骨質(zhì)疏松癥輔助診斷及自身免疫疾病的輔助診斷，旗下品牌主要有：Metra， Quidel ， QuickVue ，QuickVue In-Line ，QuickVue Advance，QuickVue+，RapidVue 等。
Quidel Corporation部分產(chǎn)品：
Quidel | MicroVue CIC-C1q EIA | A001 | 1 kit |
Quidel | MicroVue CIC Raji Cell Replacement EIA | A002 | 1 ki |
Quidel | MicroVue CIC-C1q Controls (Low and High Control) | A013 | 1 ea. |
Quidel | MicroVue CH50 Eq EIA | A018 | 1 kit |
Quidel | MicroVue Bb Plus Fragment EIA | A027 | 1 kit |
Quidel | MicroVue C1 Inhibitor Plus EIA | A037 | 1 kit |
Quidel | MicroVue iC3b Fragment EIA – For Research Use Only | A006 | 1 kit |
Quidel | MicroVue SC5b-9 Plus EIA – For Research Use Only | A020 | 1 kit |
Quidel | MicroVue C5a EIA – For Research Use Only | A021 | 1 kit |
Quidel | MicroVue C3a Plus EIA – For Research Use Only | A031 | 1 kit |
Quidel | MicroVue Ba Fragment EIA – For Research Use Only | A033 | 1 kit |
Quidel | MicroVue C4a EIA – For Research Use Only | A035 | 1 kit |
Quidel | MicroVue Animal Pan-Specific C3 Reagent Kit | 20261 | 1 kit |
Quidel | Prekallikrein Activator (PKA) Assay Kit | PW30100 | 1 kit |
Quidel | Prekallikrein Activator (PKA) EP Assay Kit | PW301EP | 1 kit |
Quidel | Prekallikrein Activator (PKA) Ig Assay Kit | PW30200 | 1 kit |
Quidel | Prekallikrein Activator (PKA) Ig EP Assay Kit | PW302EP | 1 kit |
Quidel | Just Positive PKA Control | PW51005 | 5x0.5 mL |
Quidel | High Positive PKA Control | PW52005 | 5x0.5 mL |
Quidel | Anti-human C9 | A223 | 100 µL |
Quidel | Anti-human Factor B (Ba) | A225 | 100 µL |
Quidel | Anti-human Factor B (Bb) | A227 | 100 µL |
Quidel | Anti-human Factor H #1 | A229 | 100 µL |
Quidel | Anti-human Factor I #2 | A231 | 100 µL |
Quidel | Anti-human Factor P #1 | A233 | 100 µL |
Quidel | Anti-human Factor P #2 | A235 | 100 µL |
Quidel | Anti-human S Protein (vitronectin) | A237 | 100 µL |
Quidel | Anti-human SC5b-9 (TCC, neoantigen) | A239 | 100 µL |
Quidel | Anti-human Clusterin (SP40, 40 and Apo J) | A241 | 100 µL |
Quidel | Anti-human Factor I #1 | A247 | 100 µL |
Quidel | Anti-human C8 | A249 | 100 µL |
Quidel | Anti-human C3d (neoantigen) | A250 | 100 µL |
Quidel | Anti-human C4d (neoantigen) | A251 | 100 µL |
Quidel | Anti-human Bb (neoantigen) | A252 | 100 µL |
Quidel | Anti-human C4 (C4d) | A253 | 0.5 mL |
Quidel | Anti-human Factor H #2 | A254 | 100 µL |
Quidel | Anti-human Factor H #3 | A255 | 100 µL |
